Michael C. Goodnough

Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells

Min Dong, David A. Richards, Michael C. Goodnough et al. · The Journal of Cell Biology · 2003 · 292 citations · Full text

Synaptic Transmission, Neurotransmitter, Immunology +16

An <i>in vitro</i> and <i>in vivo</i> disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists

Lisa M. Eubanks, Mark S. Hixon, Wei Jin et al. · Proceedings of the National Academy of Sciences · 2007 · 120 citations · Full text

Lead Compounds, Immunotoxicology, Toxinology +18

Pure Botulinum Neurotoxin Is Absorbed from the Stomach and Small Intestine and Produces Peripheral Neuromuscular Blockade

Andrew B. Maksymowych, Marco Reinhard, Carl J. Malizio et al. · Infection and Immunity · 1999 · 112 citations · Full text

Purification of Clostridium botulinum Type A Neurotoxin

Carl J. Malizio, Michael C. Goodnough, Eric A. Johnson · Humana Press eBooks · 2003 · 87 citations

Microbial Toxin, Bioorganic Chemistry, Toxinology +9

Botulinum Toxin for Aberrant Facial Nerve Regeneration: Double-Blind, Placebo-Controlled Trial Using Subjective Endpoints

Gary E. Borodic, Mary Bartley, William H. Slattery et al. · Plastic & Reconstructive Surgery · 2005 · 84 citations